BlackRock’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.24M | Buy |
6,520
+1,146
| +21% | +$197K | ﹤0.01% | 4291 |
|
|
2026
Q1 | $907K | Buy |
5,374
+1,157
| +27% | +$198K | ﹤0.01% | 4370 |
|
|
2025
Q4 | $712K | Buy |
4,217
+678
| +19% | +$110K | ﹤0.01% | 4399 |
|
|
2025
Q3 | $511K | Buy |
3,539
+1,233
| +53% | +$168K | ﹤0.01% | 4451 |
|
|
2025
Q2 | $292K | Sell |
2,306
-148
| -6% | -$18.2K | ﹤0.01% | 4581 |
|
|
2025
Q1 | $314K | Sell |
2,454
-395,433
| -99% | -$53.6M | ﹤0.01% | 4517 |
|
|
2024
Q4 | $52.6M | Buy |
397,887
+1,987
| +0.5% | +$279K | ﹤0.01% | 2423 |
|
|
2024
Q3 | $57.6M | Buy |
+395,900
| New | +$57.3M | ﹤0.01% | 2387 |
|
|
2023
Q3 | – | Sell |
-59,814
| Closed | -$7.59M | – | 5492 |
|
|
2023
Q2 | $7.59M | Hold |
59,814
| – | – | ﹤0.01% | 3544 |
|
|
2023
Q1 | $7.73M | Hold |
59,814
| – | – | ﹤0.01% | 3453 |
|
|
2022
Q4 | $7.85M | Hold |
59,814
| – | – | ﹤0.01% | 3504 |
|
|
2022
Q3 | $7M | Hold |
59,814
| – | – | ﹤0.01% | 3611 |
|
|
2022
Q2 | $7.04M | Hold |
59,814
| – | – | ﹤0.01% | 3668 |
|
|
2022
Q1 | $7.79M | Sell |
59,814
-727
| -1% | -$94.7K | ﹤0.01% | 3718 |
|
|
2021
Q4 | $9.24M | Hold |
60,541
| – | – | ﹤0.01% | 3720 |
|
|
2021
Q3 | $9.79M | Hold |
60,541
| – | – | ﹤0.01% | 3682 |
|
|
2021
Q2 | $9.91M | Sell |
60,541
-997
| -2% | -$154K | ﹤0.01% | 3647 |
|
|
2021
Q1 | $9.27M | Sell |
61,538
-30,768
| -33% | -$4.89M | ﹤0.01% | 3618 |
|
|
2020
Q4 | $14M | Sell |
92,306
-297
| -0.3% | -$42.4K | ﹤0.01% | 3197 |
|
|
2020
Q3 | $12.5M | Sell |
92,603
-1,915
| -2% | -$260K | ﹤0.01% | 3106 |
|
|
2020
Q2 | $12.9M | Buy |
+94,518
| New | +$12M | ﹤0.01% | 3040 |
|
|
2020
Q1 | – | Sell |
-66
| Closed | -$8K | – | 5008 |
|
|
2019
Q4 | $8K | Buy |
+66
| New | +$7.36K | ﹤0.01% | 4755 |
|
|
2019
Q2 | – | Sell |
-117
| Closed | -$13K | – | 5042 |
|
|
2019
Q1 | $13K | Buy |
+117
| New | +$12.8K | ﹤0.01% | 4646 |
|
|
2017
Q3 | – | Sell |
-300
| Closed | -$31K | – | 4993 |
|
|
2017
Q2 | $31K | Buy |
+300
| New | +$29.5K | ﹤0.01% | 4596 |
|
|
2016
Q4 | – | Sell |
-132
| Closed | -$13K | – | 3772 |
|
|
2016
Q3 | $13K | Hold |
132
| – | – | ﹤0.01% | 3359 |
|
|
2016
Q2 | $11K | Hold |
132
| – | – | ﹤0.01% | 3394 |
|
|
2016
Q1 | $11K | Sell |
132
-18
| -12% | -$1.61K | ﹤0.01% | 3110 |
|
|
2015
Q4 | $17K | Buy |
+150
| New | +$16.3K | ﹤0.01% | 2652 |
|
Other funds holding IBB
CB
BlackRock's IBB Position: Q2 2026 in Review
BlackRock increased its iShares Biotechnology ETF (IBB) stake by 21% in Q2 2026, buying an estimated $197K and bringing the position to 6,520 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4291.
BlackRock first reported a position in IBB in Q4 2015 and has held it in 28 quarters since. The position peaked at $57.6M in Q3 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- BlackRock held 6,520 shares of iShares Biotechnology ETF worth $1.24M as of Q2 2026.
- BlackRock bought 1,146 iShares Biotechnology ETF shares in Q2 2026, an estimated $197K.
- iShares Biotechnology ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4291 holding.
- BlackRock first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 28 quarters since.
- BlackRock's iShares Biotechnology ETF position peaked at $57.6M in Q3 2024.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.